Beutel, Goodman & Co’s Medtronic MDT Stock Holding History

Beutel, Goodman & Co’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$387M	Sell	4,469,174 -262,437	-6%	-$25.1M	2.63%	7
2025 Q4	$455M	Sell	4,731,611 -33,494	-0.7%	-$3.25M	2.79%	5
2025 Q3	$454M	Sell	4,765,105 -142,161	-3%	-$13.1M	2.73%	4
2025 Q2	$428M	Buy	4,907,266 +115,209	+2%	+$9.77M	2.44%	9
2025 Q1	$431M	Buy	4,792,057 +70,357	+1%	+$6.3M	2.48%	9
2024 Q4	$377M	Buy	+4,721,700	New	+$409M	2.05%	15
2018 Q1	–	Sell	-605	Closed	-$39K	–	72
2017 Q4	$39K	Buy	+605	New	+$48.5K	﹤0.01%	71

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Beutel, Goodman & Co's MDT Position: Q1 2026 in Review

Beutel, Goodman & Co reduced its Medtronic (MDT) stake by 5.5% in Q1 2026, selling an estimated $25.1M and leaving 4,469,174 shares worth $387M. The position accounts for 2.63% of the portfolio, ranked #7.

Beutel, Goodman & Co first reported a position in MDT in Q4 2017 and has held it in 7 quarters since. The position peaked at $455M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Beutel, Goodman & Co held 4,469,174 shares of Medtronic worth $387M as of Q1 2026.
Beutel, Goodman & Co sold 262,437 Medtronic shares in Q1 2026, an estimated $25.1M.
Medtronic made up 2.63% of Beutel, Goodman & Co's portfolio in Q1 2026, its #7 holding.
Beutel, Goodman & Co first reported a position in Medtronic in Q4 2017 and has held it in 7 quarters since.
Beutel, Goodman & Co's Medtronic position peaked at $455M in Q4 2025.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Beutel, Goodman & Co's 13F filing for Q1 2026, filed 15 May 2026.